ARCHIVES

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

This article is from The Cancer Letter archive.

Vol. 21 No. 34 | September 8, 1995

Download PDF Visit The Full Archive

Related Articles

NCI to Fund 122 More Grants in FY04

March 28, 2003

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

November 19, 2004

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

NCI Clinical Trials Working Group is looking for pragmatic solutions to improve cancer clinical trials system, Institute official says.

September 24, 2004